FOR PROMT PATIENT MONITORING

Celeras Dx multiplexed antibody tests provide a quick and quantitative overview of a panel of biomarkers. 

The point-of-care tests to monitor the inflammation and organ status of patients aim to support clinicians judging the inflammatory and organ status of severely ill (especially septic) patients. Following the new sepsis definition, a range of different organ markers (kidney, nervous system, heart), coagulation and inflammation biomarkers are monitored in a single test.

Celeras Dx drugs of abuse screening tests provide quantitative information about the consumption of a whole range of addictive- or psychotropic substances.  A single immuno-tests quantifies the consumption of common drugs of abuse as well as social drugs and "fashion" drugs. The tests itself offer the broadest panel of drugs of abuse tested with a single immuno-test currently available.